1. Home
  2. KALV

as 09-05-2025 4:00pm EST

$
-
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

Founded: N/A Country:
United States
United States
Employees: N/A City: CAMBRIDGE
Market Cap: 637.9M IPO Year: N/A
Target Price: $26.29 AVG Volume (30 days): 734.1K
Analyst Decision: Strong Buy Number of Analysts: 9
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -3.69 EPS Growth: N/A
52 Week Low/High: $7.30 - $16.32 Next Earning Date: 09-09-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): 221.95%

KALV Daily Stock ML Predictions

Stock Insider Trading Activity of KalVista Pharmaceuticals Inc. (KALV)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Yea Christopher KALV CHIEF DEVELOPMENT OFFICER Aug 25 '25 Sell $13.42 1,954 $26,222.68 132,052
Audhya Paul K. KALV CHIEF MEDICAL OFFICER Aug 25 '25 Sell $13.42 2,336 $31,349.12 122,505
Sweeny Nicole KALV Chief Commercial Officer Aug 25 '25 Sell $13.42 1,480 $19,861.60 32,291
Palleiko Benjamin L KALV CHIEF EXECUTIVE OFFICER Aug 22 '25 Sell $13.22 10,940 $144,657.43 386,858
Yea Christopher KALV CHIEF DEVELOPMENT OFFICER Aug 22 '25 Sell $13.22 2,362 $31,232.25 132,052
Audhya Paul K. KALV CHIEF MEDICAL OFFICER Aug 22 '25 Sell $13.22 2,942 $38,901.48 122,505
Sweeny Nicole KALV Chief Commercial Officer Aug 22 '25 Sell $13.22 1,864 $24,647.30 32,291
Palleiko Benjamin L KALV CHIEF EXECUTIVE OFFICER Aug 18 '25 Sell $13.19 4,409 $58,141.48 386,858
Yea Christopher KALV CHIEF DEVELOPMENT OFFICER Aug 18 '25 Sell $13.19 2,649 $34,932.36 132,052
Audhya Paul K. KALV CHIEF MEDICAL OFFICER Aug 18 '25 Sell $13.19 2,939 $38,756.59 122,505

Share on Social Networks: